Literature DB >> 31331623

The Transition from the Hospital to an Inpatient Rehabilitation Setting for Neurologic Patients.

Lalita R Thompson1, Nneka L Ifejika2.   

Abstract

Transitions of care from acute hospitalization to postacute rehabilitation settings evolved as a function of cost-saving changes to the Medicare Prospective Payment System. Restricted criteria for inpatient rehabilitation facility admission limited access for patients with severe physical and cognitive deficits. Once used as a resource-intense supplement to hospital care, skilled nursing facilities have metamorphosed into rehabilitation settings with limited nursing staff, lower intensity of therapies, and decreased community discharge rates. A collaborative approach to care transitions, using acute and postacute health care providers, provides the opportunity to improve this process. Early physiatry consultation is a strategy for patients with neurologic disease.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Care transition; Inpatient rehabilitation facility (IRF); Nursing; Physiatry; Physical medicine and rehabilitation; Rehabilitation; Skilled nursing facility (SNF)

Mesh:

Year:  2019        PMID: 31331623     DOI: 10.1016/j.cnur.2019.04.004

Source DB:  PubMed          Journal:  Nurs Clin North Am        ISSN: 0029-6465            Impact factor:   1.208


  2 in total

Review 1.  Current Approaches in Telehealth and Telerehabilitation for Spinal Cord Injury (TeleSCI).

Authors:  Hilary Touchett; Calvin Apodaca; Sameer Siddiqui; Donna Huang; Drew A Helmer; Jan A Lindsay; Padmavathy Ramaswamy; Kathy Marchant-Miros; Felicia Skelton
Journal:  Curr Phys Med Rehabil Rep       Date:  2022-04-26

2.  Association Between 2010 Medicare Reforms and Utilization of Postacute Inpatient Rehabilitation in Ischemic Stroke.

Authors:  Nneka L Ifejika; Farhaan Vahidy; Mathew Reeves; Ying Xian; Li Liang; Roland Matsouaka; Gregg C Fonarow; Sean I Savitz
Journal:  Am J Phys Med Rehabil       Date:  2021-07-01       Impact factor: 3.412

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.